Filing Details

Accession Number:
0001209191-17-050872
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-31 17:03:20
Reporting Period:
2016-02-27
Accepted Time:
2017-08-31 16:03:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816284 Celgene Corp CELG Pharmaceutical Preparations (2834) 222711928
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1180469 Ernest Mario C/O Celgene Corporation
86 Morris Avenue
Summit NJ 07901
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-27 12,000 $121.24 57,424 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,574 Indirect By Spouse
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $121.19 to $121.33, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  2. The number of shares reported in Column 5 is inclusive of all transactions subsequent to the February 27, 2017 transaction reported on this Form 4.
  3. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.